Sortiert nach PI

Publikationen - sortiert nach Principle Investigator

• Golse M, Weinhofer I, Blanco B, Barbier M, Yazbeck E, Huiban C, Chaumette B, Pichon B, Fatemi A, Pascual S, Martinell M, Berger J, Perlbarg V, Galanaud D, Mochel F (2024) Leriglitazone halts disease progression in adult patients with early cerebral adrenoleukodystrophy Brain,
• Wang J, Kunze M, Villoria-González A, Weinhofer I, Berger J (2024) Peroxisomal Localization of a Truncated HMG-CoA Reductase under Low Cholesterol Conditions Biomol, 14 (2): 244

• Kunze M, Alder N, Hwang I, Roussel G, Karamyshev A (2023) Editorial: Targeting signals in protein trafficking and transport Front Physiol, 14
• Tawbeh A, Raas Q, Tahri-Joutey M, Keime C, Kaiser R, Trompier D, Nasser B, Bellanger E, Dessard M, Hamon Y, Benani A, Di Cara F, Cunha Alves T, Berger J, Weinhofer I, Mandard S, Cherkaoui-Malki M, Andreoletti P, Gondcaille C, Savary S (2023) Immune response of BV-2 microglial cells is impacted by peroxisomal beta-oxidation Front Mol Neurosci, 16
• Villoria-González A, Zierfuss B, Parzer P, Heuböck E, Zujovic V, Waidhofer-Söllner P, Ponleitner M, Rommer P, Göpfert J, Forss-Petter S, Berger J, Weinhofer I (2023) Efficacy of HDAC Inhibitors in Driving Peroxisomal β-Oxidation and Immune Responses in Human Macrophages: Implications for Neuroinflammatory Disorders Biomol, 13 (12): 1696
• Werner E, Swinkels D, Juric V, Dorninger F, Baes M, Keller M, Berger J, Watschinger K (2023) Normal plasmalogen levels are maintained in tissues from mice with hepatocyte-specific deletion in peroxin 5 Brain Res Bull, 193: 158-165
• Dorninger F, Berger J, Honsho M (2023) Editorial: Solving the plasmalogen puzzle—From basic science to clinical application Front Cell Dev Biol, 11
• Weinhofer I, Rommer P, Gleiss A, Ponleitner M, Zierfuss B, Waidhofer-Söllner P, Fourcade S, Grabmeier-Pfistershammer K, Reinert M, Göpfert J, Heine A, Yska H, Casasnovas C, Cantarín V, Bergner C, Mallack E, Forss-Petter S, Aubourg P, Bley A, Engelen M, Eichler F, Lund T, Pujol A, Köhler W, Kühl J, Berger J (2023) Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophy EBioMedicine, 96: 104781
• Buda A, Forss-Petter S, Hua R, Jaspers Y, Lassnig M, Waidhofer-Söllner P, Kemp S, Kim P, Weinhofer I, Berger J (2023) ABCD1 Transporter Deficiency Results in Altered Cholesterol Homeostasis Biomol, 13 (9): 1333
• Martinović K, Bauer J, Kunze M, Berger J, Forss-Petter S (2023) Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy Acta Neuropathologica Communications, 11 (1): 98
• Dorninger F, Kiss A, Rothauer P, Stiglbauer-Tscholakoff A, Kummer S, Fallatah W, Perera-Gonzalez M, Hamza O, König T, Bober M, Cavallé-Garrido T, Braverman N, Forss-Petter S, Pifl C, Bauer J, Bittner R, Helbich T, Podesser B, Todt H, Berger J (2023) Overlapping and Distinct Features of Cardiac Pathology in Inherited Human and Murine Ether Lipid Deficiency Int J Mol Sci, 24 (3): 1884

• Dorninger F, Werner E, Berger J, Watschinger K (2022) Regulation of plasmalogen metabolism and traffic in mammals: The fog begins to lift Front Cell Dev Biol, 10
• Zierfuss B, Buda A, Villoria-González A, Logist M, Fabjan J, Parzer P, Battin C, Vandersteene S, Dijkstra I, Waidhofer-Söllner P, Grabmeier-Pfistershammer K, Steinberger P, Kemp S, Forss-Petter S, Berger J, Weinhofer I (2022) Saturated very long-chain fatty acids regulate macrophage plasticity and invasiveness J Neuroinflammation, 19 (1)
• Bernhard Hochreiter, Hugo Malagon-Vina, Johannes A. Schmid, Johannes Berger and Markus Kunze (2022) Studying the interaction between PEX5 and its full-length cargo proteins in living cells by a novel Förster´s resonance energy transfer-based competition assay Front Cell Dev Biol,
  | Weblink |
• Eden Yifrach, Markus Rudowitz, Luis Daniel Cruz-Zaragoza, Asa Tirosh , Zohar Gazi , Yoav Peleg , Markus Kunze , Miriam Eisenstein , Wolfgang Schliebs, Maya Schuldiner, Ralf Erdmann and Einat Zalckvar (2022) Determining the targeting specificity of the selective peroxisomal targeting factor Pex9 Biol.Chem.,
• Weinhofer I, Buda A, Kunze M, Palfi Z, Traunfellner M, Hesse S, Villoria-Gonzalez A, Hofmann J, Hametner S, Regelsberger G, Moser A, Eichler F, Kemp S, Bauer J, Kühl J, Forss-Petter S, Berger J (2022) Peroxisomal very long-chain fatty acid transport is targeted by herpesviruses and the antiviral host response Commun Biol, 5 (1): 944
• Fallatah W, Cui W, Di Pietro E, Carter G, Pounder B, Dorninger F, Pifl C, Moser A, Berger J, Braverman N (2022) A Pex7 Deficient Mouse Series Correlates Biochemical and Neurobehavioral Markers to Genotype Severity—Implications for the Disease Spectrum of Rhizomelic Chondrodysplasia Punctata Type 1 Front Cell Dev Biol, 10
• Dorninger F, Vaz F, Waterham H, Klinken J, Zeitler G, Forss-Petter S, Berger J, Wiesinger C (2022) Ether lipid transfer across the blood-brain and placental barriers does not improve by inactivation of the most abundant ABC transporters Brain Res Bull, 189: 69-79
• Koniuszewski F, Vogel F, Bampali K, Fabjan J, Seidel T, Scholze P, Schmiedhofer P, Langer T, Ernst M (2022) Molecular Mingling: Multimodal Predictions of Ligand Promiscuity in Pentameric Ligand-Gated Ion Channels MB, 9

• Fallatah W, Nimmo G, Yergeau C, Di Pietro E, Dorninger F, Berger J, Braverman N (2021) Molecular, biochemical and neuropathological characterization of novel PEX7 deletion variants in patients with classic (severe) rhizomelic chondrodysplasia punctata type 1 Mol Genet Metab, 132: S286
• Rodríguez-Pascau L, Vilalta A, Cerrada M, Traver E, Forss-Petter S, Weinhofer I, Bauer J, Kemp S, Pina G, Pascual S, Meya U, Musolino P, Berger J, Martinell M, Pizcueta P (2021) The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy Sci Transl Med, 13 (596): eabc0555
• Fabjan J, Koniuszewski F, Schaar B, Ernst M (2021) Structure-Guided Computational Methods Predict Multiple Distinct Binding Modes for Pyrazoloquinolinones in GABAA Receptors Front Neurosci, 14: 611953
• Raas Q, van de Beek M, Forss-Petter S, Dijkstra I, Deschiffart A, Freshner B, Stevenson T, Jaspers Y, Nagtzaam L, Wanders R, van Weeghel M, Engelen-Lee J, Engelen M, Eichler F, Berger J, Bonkowsky J, Kemp S (2021) Metabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy J Clin Invest, 131 (8)
• Weinhofer I, Rommer P, Zierfuss B, Altmann P, Foiani M, Heslegrave A, Zetterberg H, Gleiss A, Musolino P, Gong Y, Forss-Petter S, Berger T, Eichler F, Aubourg P, Köhler W, Berger J (2021) Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy Nat Commun, 12 (1)
• Simeone X, Koniuszewski F, Müllegger M, Smetka A, Steudle F, Puthenkalam R, Ernst M, Scholze P (2021) A Benzodiazepine Ligand with Improved GABAA Receptor α5-Subunit Selectivity Driven by Interactions with Loop C Mol Pharmacol, 99 (1): 39-48

• Vilalta, A.; Berger, J; Forss-Petter, S.; Bauer, J.; Weinhofer, I.; Solà, Carme CSIC ORCID; Herrando-Grabulosa, Mireia; Navarro, Xavier; Martinell, M.; Pizcueta, P (2021) Leriglitazone decreases microglia activation and promotes protective phenotypes in several neuroinflammatory models of disease Glia,

• Dorninger F, Zeitler G, Berger J (2020) Nestlet Shredding and Nest Building Tests to Assess Features of Psychiatric Disorders in Mice BioProtoc., 10 (24)
• Farr C, El-Kasaby A, Freissmuth M, Sucic S (2020) The Creatine Transporter Unfolded: A Knotty Premise in the Cerebral Creatine Deficiency Syndrome Front.Synaptic Neuroscience, 12
• Kumar P, Scholze P, Fronius M, Krasteva‐Christ G, Hollenhorst M (2020) Nicotine stimulates ion transport via metabotropic β4 subunit containing nicotinic ACh receptors Br J Pharmacol, 177 (24): 5595-5608
• Hochreiter B, Chong C, Hartig A, Maurer-Stroh S, Berger J, Schmid J, Kunze M (2020) A Novel FRET Approach Quantifies the Interaction Strength of Peroxisomal Targeting Signals and Their Receptor in Living Cells Cells, 9 (11): 2381
• Zierfuss B, Weinhofer I, Buda A, Popitsch N, Hess L, Moos V, Hametner S, Kemp S, Köhler W, Forss‐Petter S, Seiser C, Berger J (2020) Targeting foam cell formation in inflammatory brain diseases by the histone modifier MS‐275 Ann Clin Transl Neurol,
• Scholze P, Pökl M, Längle S, Steudle F, Fabjan J, Ernst M (2020) Two Distinct Populations of α1α6-Containing GABAA-Receptors in Rat Cerebellum Front.Synaptic Neuroscience, 12: 1-10
• Todt H, Dorninger F, Rothauer P, Fischer C, Schranz M, Bruegger B, Lüchtenborg C, Ebner J, Hilber K, Koenig X, Erdem F, Gawali V, Berger J (2020) Oral batyl alcohol supplementation rescues decreased cardiac conduction in ether phospholipid‐deficient mice J Inherit Metab Dis., 43: 1046-1055
• Rishi G, Secondes E, Asplett K, Wallace D, Ostini L, Berger J, Subramaniam V (2020) Dysregulated hepcidin response to dietary iron in male mice with reduced Gnpat expression Bio Rep., 40 (8): BSR20201508
• Dorninger F, Forss-Petter S, Wimmer I, Berger J (2020) Plasmalogens, platelet-activating factor and beyond – Ether lipids in signaling and neurodegeneration Neurobiol Dis, 145: 105061
• Dalby N, Falk‐Petersen C, Leurs U, Scholze P, Krall J, Frølund B, Wellendorph P (2020) Silencing of spontaneous activity at α4β1/3δ GABA A receptors in hippocampal granule cells reveals different ligand pharmacology Br J Pharmacol, 177 (17): 3975-3990
  | Article (PDF) |
• Zierfuss B, Weinhofer I, Kühl J, Köhler W, Bley A, Zauner K, Binder J, Martinović K, Seiser C, Hertzberg C, Kemp S, Egger G, Leitner G, Bauer J, Wiesinger C, Kunze M, Forss-Petter S, Berger J (2020) Vorinostat in the acute neuroinflammatory form of X-linked adrenoleukodystrophy Ann Clin Transl Neurol, 7 (5): 639-652
• Werner E, Keller M, Sailer S, Lackner K, Koch J, Hermann M, Coassin S, Golderer G, Werner-Felmayer G, Zoeller R, Hulo N, Berger J, Watschinger K (2020) TheTMEM189gene encodes plasmanylethanolamine desaturase which introduces the characteristic vinyl ether double bond into plasmalogens Proc Natl Acad Sci USA, 117 (14): 7792-7798
• Steudle F, Rehman S, Bampali K, Simeone X, Rona Z, Hauser E, Schmidt W, Scholze P, Ernst M (2020) A novel de novo variant of GABRA1 causes increased sensitivity for GABA in vitro Sci Rep, 10 (1): 2379
  | Article (PDF) |
• Iorio M, Vogel F, Koniuszewski F, Scholze P, Rehman S, Simeone X, Schnürch M, Mihovilovic M, Ernst M (2020) GABAA Receptor Ligands Often Interact with Binding Sites in the Transmembrane Domain and in the Extracellular Domain—Can the Promiscuity Code Be Cracked? Int J Mol Sci, 21 (1): 334
• Kunze M (2020) The type-2 peroxisomal targeting signal BBA Mol Cell Res, 1867 (2): 118609

• Zarrouk A, Nury T, El Hajj H, Gondcaille C, Andreoletti P, Moreau T, Cherkaoui-Malki M, Berger J, Hammami M, Lizard G, Vejux A (2020) Potential Involvement of Peroxisome in Multiple Sclerosis and Alzheimer’s Disease. In: , Advances in Experimental Medicine and Biology Springer Verlag: 91-104

• Hochreiter B, Kunze M, Moser B, Schmid J (2019) Advanced FRET normalization allows quantitative analysis of protein interactions including stoichiometries and relative affinities in living cells Sci Rep, 9 (1): 8233
  | Article (PDF) |
• Honsho M, Dorninger F, Abe Y, Setoyama D, Ohgi R, Uchiumi T, Kang D, Berger J, Fujiki Y (2019) Impaired plasmalogen synthesis dysregulates liver X receptor-dependent transcription in cerebellum J. Biochem, 166 (4): 353-361
• Chong* , Kunze* , Hochreiter , Krenn , Berger , Maurer-Stroh (*equal contribution) (2019) Rare Human Missense Variants can affect the Function of Disease-Relevant Proteins by Loss and Gain of Peroxisomal Targeting Motifs Int J Mol Sci, 20 (18): 4609
  | Article (PDF) |
• Dorninger F, Gundacker A, Zeitler G, Pollak D, Berger J (2019) Ether Lipid Deficiency in Mice Produces a Complex Behavioral Phenotype Mimicking Aspects of Human Psychiatric Disorders Int J Mol Sci, 20 (16): 3929
• Maleeva G, Wutz D, Rustler K, Nin‐Hill A, Alfonso‐Prieto M, Petukhova E, Bautista‐Barrufet A, Gomila‐Juaneda A, Scholze P, Peiretti F, Rovira C, König B, Gorostiza P, Bregestovski P (2019) A photoswitchable GABA receptor channel blocker Br J Pharmacol, 176(15): 2661-2677
• Dorninger F, König T, Scholze P, Berger M, Zeitler G, Wiesinger C, Gundacker A, Pollak D, Huck S, Just W, Forss-Petter S, Pifl C, Berger J (2019) Disturbed Neurotransmitter Homeostasis in Ether Lipid Deficiency Hum Mol Genet, 28(12): 2046-2061

• Forget B, Scholze P, Langa F, Morel C, Pons S, Mondoloni S, Besson M, Durand-de Cuttoli R, Hay A, Tricoire L, Lambolez B, Mourot A, Faure P, Maskos U (2018) A Human Polymorphism in CHRNA5 Is Linked to Relapse to Nicotine Seeking in Transgenic Rats Curr Biol., 28 (20): 3244-3253.e7
• Siebert D, Bampali K, Puthenkalam R, Varagic Z, Sarto-Jackson I, Scholze P, Sieghart W, Mihovilovic M, Schnürch M, Ernst M (2018) Engineered Flumazenil Recognition Site Provides Mechanistic Insight Governing Benzodiazepine Modulation in GABAA Receptors ACS Chem Biol, 13: 2040-2047
• Siebert D, Wieder M, Schlener L, Scholze P, Boresch S, Langer T, Schnürch M, Mihovilovic M, Richter L, Ernst M, Ecker G (2018) SAR-Guided Scoring Function and Mutational Validation Reveal Binding Mode of CGS-8216 at the α1+/γ2- Benzodiazepine Site J Chem Inf Model., 58 (8): 1682-1696
• Elgarf A, Siebert D, Steudle F, Draxler A, Li G, Huang S, Cook J, Ernst M, Scholze P (2018) Different Benzodiazepines Bind with Distinct Binding Modes to GABAA Receptors ACS Chem Biol, 13 (8): 2033-2039
• Weinhofer I, Zierfuss B, Hametner S, Wagner M, Popitsch N, Machacek C, Bartolini B, Zlabinger G, Ohradanova-Repic A, Stockinger H, Köhler W, Höftberger R, Regelsberger G, Forss-Petter S, Lassmann H, Berger J (2018) Impaired plasticity of macrophages in X-linked adrenoleukodystrophy Brain, 141: 2329-2342
  | Article (PDF) |
• Dorninger F, Moser A, Kou J, Wiesinger C, Forss-Petter S, Gleiss A, Hinterberger M, Jungwirth S, Fischer P, Berger J (2018) Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer’s Disease Mimic Accelerated Aging J. Alzheimers Dis., 62 (2): 841-854
  | Article (PDF) |

• Wongsamitkul N, Maldifassi M, Simeone X, Baur R, Ernst M, Sigel E (2017) α subunits in GABAA receptors are dispensable for GABA and diazepam action Sci Rep, 7 (1)
• Simeone X, Siebert D, Bampali K, Varagic Z, Treven M, Rehman S, Pyszkowski J, Holzinger R, Steudle F, Scholze P, Mihovilovic M, Schnürch M, Ernst M (2017) Molecular tools for GABAA receptors: High affinity ligands for β1-containing subtypes Sci Rep, 7 (1) : 5674
• Trigueros-Motos L, van Capelleveen J, Torta F, Castaño D, Zhang LH, Chai C, Kang M, Dimova L, Schimmel A, Tietjen I, Radomski C, Tan L, Hwee T, Narayanaswamy P, Wu D, Dorninger F, Yakala G, Barhdadi A, Angeli V, Dubé M, Berger J, Dallinga-Thie G, Tietge U, Wenk M, Hayden M, Hovingh G, Singaraja R (2017) ABCA8 Regulates Cholesterol Efflux and High-Density Lipoprotein Cholesterol Levels Arterioscler Thromb Vasc Biol, 37: 2147-2155
• Dorninger F, Herbst R, Kravic B, Camurdanoglu B, Macinkovic I, Zeitler G, Forss-Petter S, Strack S, Khan M, Waterham H, Rudolf R, Hashemolhosseini S, Berger J (2017) Reduced Muscle Strength in Ether Lipid-Deficient Mice Is Accompanied by Altered Development and Function of the Neuromuscular Junction J Neurochem, 143: 569-583
  | Article (PDF) |

• Dorninger F, Forss-Petter S, Berger J (2017) From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system FEBS Letters, 591: 2761-2788
  | Article (PDF) |

• Puthenkalam R, Hieckel M, Simeone X, Suwattanasophon C, Feldbauer R, Ecker G, Ernst M (2016) Structural Studies of GABAA Receptor Binding Sites: Which Experimental Structure Tells us What? Front Mol Neurosci, 16;9:44
• Stamenić T, Poe M, Rehman S, Santrač A, Divović B, Scholze P, Ernst M, Cook J, Savić M (2016) Ester to amide substitution improves selectivity, efficacy and kinetic behavior of a benzodiazepine positive modulator of GABAA receptors containing the α5 subunit Eur J Pharmacol, 791: 433-443

• Berger J, Dorninger F, Forss-Petter S, Kunze M (2016) Peroxisomes in brain development and function Biochim Biophys Acta, 863: 934-955
  | Article (PDF) |

• Kunze M, Berger J (2015) The similarity between N-terminal targeting signals for protein import into different organelles and its evolutionary relevance Front Physiol, 6: 1-27
• Jung G, Kim E, Cicvaric A, Sase S, Gröger M, Höger H, Sialana F, Berger J, Monje F, Lubec G (2015) Drebrin depletion alters neurotransmitter receptor levels in protein complexes, dendritic spine morphogenesis and memory-related synaptic plasticity in the mouse hippocampus J Neurochem, 134 (2): 327-339
• Dorninger F, Wiesinger C, Braverman N, Forss-Petter S, Berger J (2015) Ether Lipid Deficiency Does Not Cause Neutropenia or Leukopenia in Mice and Men Cell Metab, 21 (5): 650-651
• Kunze M, Malkani N, Maurer-Stroh S, Wiesinger C, Schmid J, Berger J (2015) Mechanistic Insights into PTS2-mediated Peroxisomal Protein Import: The Co-receptor PEX5L drastically increases the Interaction Strength between the Cargo Protein and the Receptor PEX7 J Biol Chem, 290: 4928-4940
  | Article (PDF) |
• Dorninger F, Brodde A, Braverman N.E, Moser A.B, Just W, Forss-Petter S, Brügger B. Berger J, (2015) Homeostasis of Phospholipids – The Level of Phosphatidylethanolamine Tightly Adapts to Changes in Ethanolamine Plasmalogens Biochim Biophys Acta, 1851: 117-128
  | Article (PDF) |
• Ghafari M, Whittle N, Miklósi A, Kotlowsky C, Schmuckermair C, Berger J, Bennett K, Singewald N, Lubec G (2015) Dietary magnesium restriction reduces amygdala–hypothalamic GluN1 receptor complex levels in mice Brain Struct Funct, 220 (4): 2209-2221
  | Article (PDF) |

• Wiesinger C, Eichler F, Berger J, (2015) The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis Appl Clin Genet, 8: 109
  | Article (PDF) |

• Muneer Z, Wiesinger C, Voigtländer T, Werner H, Berger J, Forss-Petter S (2014) Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice PLoS One, 9 (9): e108655
  | Article (PDF) |
• Weber F, Weinhofer I, Einwich A, Forss-Petter S, Muneer Z, Maier H, Weber W, Berger J (2014) Evaluation of Retinoids for Induction of the Redundant Gene ABCD2 as an Alternative Treatment Option in X-Linked Adrenoleukodystrophy PLoS One, 9 (7): e103742
  | Article (PDF) |
• Saroja S, Sase A, Kircher S, Wan J, Berger J, Höger H, Pollak A, Lubec G (2014) Hippocampal proteoglycans brevican and versican are linked to spatial memory of Sprague-Dawley rats in the morris water maze J Neurochem, 130 (6): 797-804
• Weber F, Wiesinger Ch, Forss-Petter S, Regelsberger G, Einwich A, Weber W, Köhler W, Stockinger H, Berger J, (2014) X-linked adrenoleukodystrophy: Very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes Hum Mol Genet, 23 (10): 2542-2550
  | Article (PDF) |
• Gondcaille C, C.Genin E, E.Lopez T, MM.Dias A, Geillon F, Andreoletti P, Cherkaoui-Malki M, Nury T, Lizard G, Weinhofer-Molisch I, Berger J, T.Kase E, Trompier D, Savary St, (2014) LXR antagonists induce ABCD2 expression Biochim Biophys Acta, 1841(2): 259-266
  | Article (PDF) |

• Berger J, Forss-Petter S, Eichler F.S, (2014) Pathophysiologie of X-linked adrenoleukodystrophy Biochimie, 98: 135-142
  | Article (PDF) |

• Kunze M, Berger J (2014) Single Peroxisomal Enzyme and Transporter Deficiencies in Human Diseases and Mouse Models. In: , Molecular Machines Involved in Peroxisome Biogenesis and Maintenance Springer Vienna: pp 153-184
  | Weblink |

• Wang B, Van Veldhoven P, Brees C, Rubio N, Nordgren M, Apanasets O, Kunze M, Baes M, Agostinis P, Fransen M (2013) Mitochondria are targets for peroxisome-derived oxidative stress in cultured mammalian cells FREE RADICAL BIO MED , 65: 882-894
  | Article (PDF) |
• Wiesinger C, Kunze M, Regelsberger G, Forss-Petter S, Berger J. (2013) Impaired Very Long-Chain Acyl-CoA β-Oxidation in Human X-ALD Fibroblasts Is a Direct Consequence of ABCD1 Transporter Dysfunction J Biol Chem, 288: 19269-19279

• Weinhofer I, Kunze M, Forss-Petter S, Berger J (2013) Involvement of Human Peroxisomes in Biosynthesis and Signaling of Steroid and Peptide Hormones. In: del Río, Luis A. (Ed.), Subcellular Biochemistry Vol. 69: Peroxisomes and their Key Role in Cellular Signaling and Metabolism Springer Verlag, Heidelberg: pp 101-110

• Schmied M, Zehetmayer S, Reindl M, Ehling R, Bajer-Kornek B, Leutmezer F, Zebenholzer K, Hotzy C, Lichtner P, Meitinger T, Wichmann H, Illig T, Gieger C, Huber K, Khalil M, Fuchs S, Schmidt H, Auff E, Kristoferitsch W, Fazekas F, Berger T, Vass K, Zimprich A (2012) Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patients Neurogenetics, 13 (2): 181-187
• Brodde A, Teigler A, Brugger B, Lehmann WD, Wieland F, Berger J, Just WW. (2012) Impaired neurotransmission in ether lipid-deficient nerve terminals Hum Mol Genet, 21(12): 2713-2724.
  | Article (PDF) |
• Preusser M, Hassler M, Birner P, Rudas M, Acker T, Plate H, Widhalm G, Knosp E, Breitschopf H, Berger J, Marosi C. (2012) Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches Clin Neuropathol, 31(5): 352-360
• Facciotti F, Ramanjaneyulu GS, Lepore M, Sansano S, Cavallari M, Kistowska M, Forss-Petter S, Ni G, Colone A, Singhal A, Berger J, Xia C, Mori L, De Libero G (2012) Peroxisome-derived lipids are self-antigens stimulating invariant Natural Killer T cells in the thymus Nature Immunol, 13(5): 474-480.
• Barbier M, Sabbagh A, Kasper E, Asheuer M, Ahouansou O, Pribill I, Forss-Petter S, Vidaud M, Berger J, Aubourg P (2012) CD1 gene polymorphisms and phenotypic variability in X-linked adrenoleukodystrophy PLoS.ONE., 7(1): e29872
  | Article (PDF) |

• Kemp S, Berger J, Aubourg P (2012) X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects BBA, 1822 (9): 1465-1474

• Kunze M, Neuberger G, Maurer-Stroh S, Ma J, Eck T, Braverman N, Schmid J, Eisenhaber F, Berger J. (2011) Structural requirements for the interaction of peroxisomal targeting signal 2 and its receptor PEX7 J Biol Chem, 286(52): 45048-45062
  | Article (PDF) |
• Kou J, Kovacs GG, Höftberger R, Kulik W, Brodde A, Forss-Petter S, Hönigschnabl S, Gleiss A, Brügger B, Wanders R, Just W, Budka H, Jungwirth S, Fischer P, Berger J. (2011) Peroxisomal alterations in Alzheimer's disease Acta Neuropathol, 122: 271-283
  | Article (PDF) |

• Höftberger R, Kunze M, Voigtländer T, Unterberger U, Regelsberger G, Bauer J, Aboul-Enein F, Garzuly F, Forss-Petter S, Bernheimer H, Berger J, Budka H (2010) Peroxisomal Localization of the Proopiomelanocortin-Derived Peptides β-Lipotropin and β-Endorphin Endocrinology, 151 (10): 4801-4810
  | Article (PDF) |

• Weinhofer I, Kunze M, Rampler H, Forss-Petter S, Samarut J, Plateroti M, Berger J (2008) Distinct modulatory roles for thyroid hormone receptors TR-alpha and TR-beta in SREBP1-activated ABCD2 expression Eur J Cell Biol, 87: 933-945
  | Article (PDF) |

• Höftberger R, Kunze M, Weinhofer I, Aboul-Enein F, Voigtländer T, Oezen I, Amann G, Bernheimer H, Budka H, Berger J (2007) Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: Implications for X-linked adrenoleukodystrophy Neurobiol Dis, 28 (2): 165-174
• Barceló-Coblijn G., Golkovko MY., Weinhofer I., Berger J., Murphy E.J. (2007) Brain neutral lipids mass is increased in a-synuclein gene ablated mice J Neurochem, 101: 132-141
• Dumser M, Bauer J, Lassmann H, Berger J, Forss-Petter S (2007) Lack of adrenoleukodystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1/Mag deficiency Acta Neuropathol, 114;6: 573-586

• Weinhofer I., Kunze M., Stangl H., Porter F.D., Berger J (2006) Peroxisomal cholesterol biosynthesis and Smith-Lemli-Opitz syndrome. Biochem Bioph Res Comm, 345: 205-209

• Weinhofer I., Forss-Petter S., Kunze M., Zigman M., Berger J. (2005) X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism FEBS Letters, 579: 5512-5516
• Weinhofer I., Kunze M., Rampler H., Bookout A.L., Forss-Petter S., Berger J (2005) LXRalpha interferes with SREBP1c-mediated Abcd2 expression: novel cross-talk in gene regulation J Biol Chem, 280: 41243-41251

• Weinhofer I, Forss-Petter S, Zigman M, Berger J (2003) Cholesterol regulates ABCD2 gene expression: implications for X-linked adrenoleukodstrophy Adv Exp Med Biol, 544: 331-332
• Lassmann H., Reindl M., Rauschka H., Berger J., Aboul-Enein F., Berger T., Zurbriggen A., Luterotti A., Brück W., Weber JR., Ullrich R., Schmidbauer M., Jellinger K., Vanddevelde M. (2003) A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesions Brain, 126: 1347-1357
• Rampler H., Weinhofer I., Netik A., Forss-Petter S., Brown PJ., Oplinger JA., Bugaut M., Berger J (2003) Evaluation of the therapeutic potential of PPAR alpha agonists for X-linked adrenoleukodystrophy. Mol Genet Metab, 80: 398-407

• Berger J, Kunze M, Forss-Petter S (2003) Lessons from Knockout Mice II: Mouse Models for Peroxisomal Disorders with Single Protein Deficiency. In: , Advances in Experimental Medicine and Biology Springer Verlag: 123-134

• Kunze M, Kragler F, Binder M, Hartig A, Gurvitz A (2002) Targeting of malate synthase 1 to the peroxisomes of Saccharomyces cerevisiae cells depends on growth on oleic acid medium Eur J Biochem, 269 (3): 915-922
  | Article (PDF) |
• Weinhofer I., Forss-Petter S., Zigman M., Berger J (2002) Cholesterol regulates ABCD2 expression: Implication for therapy of X-linked adrenoleukodystrophy Hum Mol Genet, 11: 2701-2708